Daktari Awarded NIH SBIR for HCV

The NIH has awarded Daktari with a grant to develop a point-of-care hepatitis C diagnostic system.  Hepatitis C has emerged as a major global pandemic, affecting nearly 175 million people worldwide.  This grant enables the company to develop new diagnostic tests beyond its initial focus on HIV care.  The grant was part of the NIH SBIR Fast Track program.